Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease

The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn’s Disease in the Biosimilar Era

(2019) Abhinav Vasudevan et al.   INFLAMMATORY BOWEL DISEASES

Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease

(2018) Abhinav Vasudevan et al.   DIGESTIVE AND LIVER DISEASE

Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis

(2018) Hans Herfarth et al.   GASTROENTEROLOGY

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases—A Clinical Practice Update: Commentary

(2018) Stephen B. Hanauer et al.   GASTROENTEROLOGY

Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration

(2016) Gerolamo Bianchi et al.   ADVANCES IN THERAPY

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

(2016) Franck Carbonnel et al.   GASTROENTEROLOGY

Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis

(2016) Michael H. Schiff et al.   RHEUMATOLOGY INTERNATIONAL

Thiopurines in the Management of Crohn’s Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study

(2016) Amine Benmassaoud et al.   Canadian Journal of Gastroenterology and Hepatology

Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis

(2015) Olga Niewiadomski et al.   Journal of Crohns & Colitis

Association Between Thiopurine Use and Nonmelanoma Skin Cancers in Patients With Inflammatory Bowel Disease: A Meta-Analysis

(2014) Jonathan Ariyaratnam et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease

(2013) T. Dassopoulos et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

(2012) Mirthe Emilie van der Valk et al.   GUT

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol

(2012) Melissa A. Smith et al.   Journal of Crohns & Colitis

Multiple imputation by chained equations: what is it and how does it work?

(2011) Melissa J. Azur et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

(2008) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: A case for subcutaneous administration

(2007) Debbie M Nathan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY